The data from preclinical studies suggest that CD34+ cells differentiate into endothelial cells, integrate into the vasculature, and secrete angiogenic factors, promoting vessel regeneration in the microcirculation and improving myocardial perfusion in ischemia-induced tissue injury [17]. This evidence concerns the gene CD34 and ischemia.